Table 1.: Comparison of siRNA with Current Treatments

siRNA Chemo/radiation Vaccine
Target All HPV Genes All cells L1, L2
Prophylactic
Therapeutic
Long-lasting
Specificity High Low High
HPV types All All 2-4
Warts
CIN/AIN/VIN
Laryngeal Papillomatosis

SiRNA therapies show major advantages over other forms of treatment including specificity, broad application and reduced toxicity. CIN, cervical intraepithelial neoplasia; AIN, anal intraepithelial neoplasia; VIN, vulval intraepithelial neoplasia.